Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.

Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.

Allergies and anaphylaxis: Parenteral epinephrine is highly effective in treating allergic reactions and anaphylaxis, relieving symptoms such as itching, hives, edema, and airway narrowing. It suppresses the release of mediators like histamine.

Respiratory conditions: β-agonists are used to treat asthma. Isoproterenol, epinephrine, and selective β2-agonists like salmeterol are commonly used bronchodilators.

Central nervous system disorders: Indirect and mixed-acting agonists with good CNS penetration regulate brain dysfunction in conditions like narcolepsy and ADHD, producing mood-enhancing and stimulatory effects.

Nasal decongestion: Oxymetazoline and other nasal decongestants are employed to treat colds, rhinitis, sinusitis, and blocked noses in various forms.

Ophthalmology: Phenylephrine is utilized as a mydriatic in eyedrops for fundus examination.

Incontinence treatment: β3-agonists like mirabegron are employed to treat urinary incontinence.

Adrenergic agonists have many therapeutic applications. They provide valuable interventions in emergencies and help manage various medical conditions.

From Chapter 6:

article

Now Playing

6.10 : Adrenergic Agonists: Therapeutic Uses

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

620 Views

article

6.1 : Adrenergic Neurons: Neurotransmission

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.0K Views

article

6.2 : Adrenergic Receptors (Adrenoceptors): Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.9K Views

article

6.3 : Adrenergic Receptors: ɑ Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Views

article

6.4 : Adrenergic Receptors: β Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Views

article

6.5 : Adrenergic Agonists: Direct-Acting Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Views

article

6.6 : Adrenergic Agonists: Indirect-Acting Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Views

article

6.7 : Adrenergic Agonists: Mixed-Action Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

548 Views

article

6.8 : Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.4K Views

article

6.9 : Adrenergic Agonists: Therapeutic Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

538 Views

article

6.11 : Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

692 Views

article

6.12 : Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

450 Views

article

6.13 : Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

412 Views

article

6.14 : Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

424 Views

article

6.15 : Adrenergic Antagonists: ɑ and β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

341 Views

See More

We use cookies to enhance your experience on our website.

By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.

Learn More